相关实验视频
Updated: Jul 6, 2025

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.5K
作为癌症调节器的desmoglein-2:朋友还是敌人?
Kay K Myo Min1, Charlie B Ffrench1, Barbara J McClure1,2
1Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, Australia.
Frontiers in oncology
|January 8, 2024
概括
德斯莫格林-2 (DSG2) 是一种细胞粘附蛋白,在癌症中扮演着新兴的角色. 了解它的非正典功能可能会导致新的预后生物标志物和癌症患者的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 德斯莫格林-2 (DSG2) 是一种属于卡德林家族的跨膜糖蛋白.
- 传统上被认为是由于其在脱体介导的细胞粘附和机械应激耐受性方面的作用.
- 新出现的证据凸显了DSG2在其正规功能之外的各种细胞过程中的参与.
研究的目的:
- 在癌症的背景下审查关于Desmoglein-2 (DSG2) 的当前文献.
- 详细说明DSG2对关键生物功能的影响,这些功能与癌症进展有关.
- 探索DSG2作为预后生物标志物和治疗点的潜力.
主要方法:
- 对研究癌症中DSG2的综合文献综述.
- 分析DSG2在细胞粘附,增殖,迁移,入侵,信号传递,细胞外囊泡释放和血管仿真中的作用.
- 在瘤发生过程中合成正规和非正规的DSG2功能.
主要成果:
- DSG2在癌症中表现出多样化的功能,超出了细胞粘附范围.
- DSG2影响癌症的关键特征,包括扩散,迁移和入侵.
- 非正规的DSG2功能有助于癌症的进展,可能取决于上下文.
结论:
- DSG2在癌症生物学中扮演着多方面的角色,无论是在desmosomes内外.
- 了解这些多样化的功能对于开发新型癌症疗法至关重要.
- 通过向治疗或作为预后标志物,DSG2代表了改善患者结果的有希望的目标.
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Desmosomes
5.4K
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein...
5.4K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

